Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0IX2C
|
|||
| Drug Name |
Quinazolinedione derivative 2
|
|||
| Synonyms |
PMID27841036-Compound-12
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
Impact Therapeutics Inc
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C24H21FN6O3
|
|||
| Canonical SMILES |
C1CN(CCN1C2=NC=CC=N2)C(=O)C3=CC=CC(=C3)CN4C5=C(C(=CC=C5)F)C(=O)NC4=O
|
|||
| InChI |
1S/C24H21FN6O3/c25-18-6-2-7-19-20(18)21(32)28-24(34)31(19)15-16-4-1-5-17(14-16)22(33)29-10-12-30(13-11-29)23-26-8-3-9-27-23/h1-9,14H,10-13,15H2,(H,28,32,34)
|
|||
| InChIKey |
QUTRGYJIPOIOGH-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Poly [ADP-ribose] polymerase 1 (PARP1) | Target Info | Inhibitor | [1] |
| Target's Patent Info | Poly [ADP-ribose] polymerase 1 (PARP1) | Target's Patent Info | [1] | |
| KEGG Pathway | Base excision repair | |||
| NF-kappa B signaling pathway | ||||
| Panther Pathway | FAS signaling pathway | |||
| Pathway Interaction Database | Integrin-linked kinase signaling | |||
| Caspase Cascade in Apoptosis | ||||
| Notch-mediated HES/HEY network | ||||
| Reactome | Dual Incision in GG-NER | |||
| WikiPathways | FAS pathway and Stress induction of HSP regulation | |||
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | ||||
| Nanoparticle triggered regulated necrosis | ||||
| Corticotropin-releasing hormone | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | PARP inhibitors as antitumor agents: a patent update (2013-2015).Expert Opin Ther Pat. 2017 Mar;27(3):363-382. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.